| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/15/2010 | US7737261 Avermectin B1 and avermectin B1 monosaccharide derivatives having an alkoxymethyl substituent in the 4″ -or 4′-position |
| 06/15/2010 | US7737214 cross-linking polysaccharide derivative containing at least one active ester group introduced in a polysaccharide side chain, which is capable of reacting with an active hydrogen-containing group; avoid risks as caused by using a non-biologically derived material |
| 06/15/2010 | US7737186 mixture of 2-amino-1,3,4-octadecanetriol and lipolytic agents, which stimulates the synthesis of leptin by adipocytes, for reducing subcutaneous fats |
| 06/15/2010 | US7737185 treating wasting in a hypogonadal male with chronic obstructive pulmonary disorder, especially a loss of muscle mass; reducing side effects while elevating serum testosterone levels |
| 06/15/2010 | US7737184 2-(3-Phenyl-ureido)-octanedioic acid 8-hydroxyamide 1-phenylamide; 4-(2-Hydroxycarbamoyl-vinyl)-N,N-bis-phenylcarbamoylmethyl-benzamide; useful in treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, and neurdegenerative disorders |
| 06/15/2010 | US7737183 β-amyloid and neurofibrillary tangle imaging agents |
| 06/15/2010 | US7737182 Applying a prostaglandin D receptor selective agonist, e.g., a 1R,2R,3R,5R)-5-halo-2-[(1E,3S)-3-cycloalkyl-3-hydroxy-1-propenyl]-3-hydroxycyclopentyl]-(5Z)-5-alkenoic acid; in particular treating senile xeroderma. |
| 06/15/2010 | US7737181 Topical adapalene for acne and other inflammatory or proliferative skin disorders |
| 06/15/2010 | US7737180 treating schizophrenia in a patient by administering an effective amount of 4,4-dimethylcyclohexylamine |
| 06/15/2010 | US7737179 Methods for treatment of dermatological conditions |
| 06/15/2010 | US7737178 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases; reduced side effects; 13-hydroxy-DHA (13-hydroxy-DHA) |
| 06/15/2010 | US7737177 Combining solution of pseudomonic acid in water-immiscible solvent with suspension or solution of calcium C2-C12 organic carboxylate in aqueous solvent to form aqueous and nonaqueous phases, wherein mupirocin calcium dihydrate precipitates |
| 06/15/2010 | US7737176 Substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them |
| 06/15/2010 | US7737175 administering a histone deacetylase enzyme inhibitor for increasing muscle fiber formation in body; decreasing inflammatory cytokine activity in a cell |
| 06/15/2010 | US7737174 6-Chloro-N-3,4-dihydroxybutyl)-5-fluoro-4'-(4-fluorophenyl)-2'-neopentyl-2-oxyspiro[indoline-3,3'-pyrrolidine]-5'-carboxamide; antagonists of the interaction p53 and MDM2 proteins; anticarcinogenic, -proliferative agents; side effect protection of cancer therapy; sensitizers to apoptosis inducers |
| 06/15/2010 | US7737173 1-Benzyl-5-hydroxy-2-methyl-1H-indole-3-carboxylic Acid, 3,5-Difluorobenzylamide, useful for treating vision defects, angiogenesis, cardiovascular disorders and as wound healing agents |
| 06/15/2010 | US7737172 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one, used for treating cellular proliferative disorders, nonproliferative degenerative disorders and viral diseases or infections |
| 06/15/2010 | US7737171 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS |
| 06/15/2010 | US7737170 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS |
| 06/15/2010 | US7737169 as caged compounds from which effector species such as neurotransmitters and amino acids are releasable on irradiation with light |
| 06/15/2010 | US7737168 Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 06/15/2010 | US7737167 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 06/15/2010 | US7737166 such as 2-tert-Butyl-7-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-5-methyl-6-phenyl-1,3-benzoxazole-4-carbonitrile hydrochloride, a 1,6-beta-glucan synthetase inhibitor having potent growth inhibition, used treating a fungal infections; fungicides |
| 06/15/2010 | US7737165 Methods of reducing weight gain associated with olanzapine treatment |
| 06/15/2010 | US7737164 Cyanopyridine antibacterial agents |
| 06/15/2010 | US7737163 Benzimidazolone carboxylic acid derivatives |
| 06/15/2010 | US7737162 Viral inhibitors |
| 06/15/2010 | US7737161 such as 5-amino-N-(5-chloropyridin-2-yl)-3-{[(trans-4-pyrrolidin-1-ylcyclohexyl)carbonyl]amino}furo[3,2-b]pyridine-2-carboxamide, used as activated blood coagulation factor X inhibitors |
| 06/15/2010 | US7737160 Protein tyrosine kinase inhibitors such as N-[4-(4-aminothieno[3,2-]pyridin-3-yl)-2-fluorophenyl]-N'-(3'-methylphenyl)urea, used for treating lung, breast, colon or hematopoietic cancer |
| 06/15/2010 | US7737159 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections |
| 06/15/2010 | US7737158 Processes for regulating blood glucose in a mammal |
| 06/15/2010 | US7737157 such as 6-((2-(3-(dimethylamino)phenylamino)pyrimidin-4-yl)(methyl)amino)-N,2-dimethylbenzofuran-3-carboxamide, used for treating angiogenesis-related disorders selected from rheumatoid arthritis, age-related macular degeneration and psoriasis; inhibitors of kinase insert domain receptor (KDR) |
| 06/15/2010 | US7737156 6-(Cyclohexylmethyl)-1-(1-ethylpropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, administered to humans or animals, to improve perception, concentration, cognition, learning and/or memory, as a consequence of dementia, stroke, brain trauma, Alzheimer's disease, Parkinson's disease or depression |
| 06/15/2010 | US7737155 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases |
| 06/15/2010 | US7737154 CRF receptor antagonists and methods relating thereto |
| 06/15/2010 | US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 06/15/2010 | US7737152 6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds |
| 06/15/2010 | US7737151 such as N-(4-(6-(5-methylthiazol-2ylamino)pyrazin-2-ylthio)phenyl)cyclopropanecarboxamide, used treating or preventing autoimmune, inflammatory and neurodegenerative diseases, bone, metabolic, nervous system and cardiovascular disorders, cancer, allergies, asthma and Alzheimer's disease |
| 06/15/2010 | US7737150 N-((S)-4,4-dimethyl-1-oxo-1-((3aS,6aR)-3-oxo-dihydro-2H-furo[3,2-b]pyrrol-4(5H6H, 6aH)-yl)pentan-2-yl)-4-(4-methylpiperazin-1-yl)benzamide; treatment of a disease selected from osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalaemia, metabolic bone disease, bone cancer |
| 06/15/2010 | US7737149 Heterocyclic amides as anticancer agents |
| 06/15/2010 | US7737148 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors |
| 06/15/2010 | US7737147 Administering l-deprenyl or propargylamine compounds; treating male and female sexual disorders, brain disorders, vascular disorders, anorectal disorders, stroke or inflammatory disorders, and depression |
| 06/15/2010 | US7737146 Compound, useful for pancreatic lipase inhibition and the process for isolation thereof |
| 06/15/2010 | US7737145 Diamine derivatives as inhibitors of leukotriene A4 hydrolase |
| 06/15/2010 | US7737144 1-Ethyl-6-methyl-3-phenyl-1H-pyrinido[5,4-e]1,2,4]triazine-5,7-dione, used for lowering blood sugar, treating non-insulin dependent diabetes and insulin resistance; antidiabetic agents |
| 06/15/2010 | US7737143 such as 6-(1H-Benzimidazol-1-yl)-N-benzylpyrazin-2-amine, used as antidiabetic, anticarcinogenic and antiarthritic agents or for treating autoimmune diseases |
| 06/15/2010 | US7737142 (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 06/15/2010 | US7737141 Prodrug of cinnamide compound |
| 06/15/2010 | US7737140 Therapeutic compounds |
| 06/15/2010 | US7737139 useful in inhibiting the chernotactic activation of neutrophils, induced by the interaction of Interleukin-8 (IL-8) with chemokine membrane receptors |
| 06/15/2010 | US7737138 Methods of treatment of a tauopathy condition comprising the use of thioninium compounds |
| 06/15/2010 | US7737137 Treating non-insulin dependent diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome; 6-[(1-cycloheptyl-4,4-dimethyl-5-oxopyrrolidin-3-yl)methoxy]nicotinonitrile for example |
| 06/15/2010 | US7737136 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives |
| 06/15/2010 | US7737135 (2S)-2-[[4'-(methylsulfonyl)-3',5-bis(trifluoromethyl)[1,1'-biphenyl]-2-yl]oxy]-propanoic acid for example; asthma or rhinitis; orphan receptor CRTH2 modulators, prostaglandin D2 is a ligand of CRTH2 |
| 06/15/2010 | US7737134 pateamine A analogs, having antiproliferative effects in vivo and in vitro by a novel drug mechanism of action, including inhibition of eukaryotic initiation factor-4A (eIF4A)-dependent translation initiation, causing cell cycle arrest or inducing apoptosis in transformed cells; treatment of leukemia |
| 06/15/2010 | US7737133 Formulations and methods of treating inflammatory bowel disease |
| 06/15/2010 | US7737132 potentiating activity of an antibiotic to inhibit growth of a bacterium which is resistant to said antibiotic, by contacting the bacterium with said antibiotic and a new class of antibiotics which are derivatives of beta-cyclodextrin, which is a cyclic molecule comprising seven D-glucose units |
| 06/15/2010 | US7737131 Multifunctional and biologically active matrices from multicomponent polymeric solutions |
| 06/15/2010 | US7737130 Pharmaceutical compositions for topical use in treatment of skin or mucous injuries |
| 06/15/2010 | US7737129 Treating sepsis, septicemia and septic shock |
| 06/15/2010 | US7737128 treating an individual exhibiting one or more symptoms of bipolar disorder by administering to the individual a therapeutically-effective amount of a uridine composition that provides 1 to 7 grams of uridine per day |
| 06/15/2010 | US7737127 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
| 06/15/2010 | US7737126 agonist of adenosine A2A receptor; treatment of asthma and chronic obstructive pulmonary disease; example: (2R,3R,4S,5R,2'R,3'R,4'S,5'R)-2,2'-{trans-1,4-cyclohexanediylbis[imino(2-{[2-(1-methyl-1H-imidazol-4-yl)ethyl]amino}-9H-purine-6,9-diyl)]}bis[5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol] |
| 06/15/2010 | US7737124 transfecting a packaging cell line with a retroviral construct, then recovering a recombinant retrovirus from the packaging cell line and infecting a target cell ex vivo with the recombinant retrovirus; downregulating chemokine receptors (CCR5); treatment of viral diseases |
| 06/15/2010 | US7737123 Multidrug resistant anticancer anthracyclines |
| 06/15/2010 | US7737122 controlling arthropod pests such as beetles, cockroaches, or ants by dispersing spinosyn compositions in the form of aerosols, fogs, smokes, or vapors |
| 06/15/2010 | US7737121 Insulin secretion by anthocyanins and anthocyanidins |
| 06/15/2010 | US7737118 Alternating intrathecal administration to the mammal of a pharmaceutically effective dose of opioid receptor agonist for first period of time, and dose of at least one opioid receptor-like receptor 1 agonist for a second period of time |
| 06/15/2010 | US7737108 Enhanced transport using membrane disruptive agents |
| 06/15/2010 | US7736885 Method for production of arachidonic acid |
| 06/15/2010 | US7736873 An isolated nucleic acid molecule comprising a nucleotide sequence which encodes the polypeptide comprising the outer membrane protein antigens of gramnegative bacteria, which can be used to prevent and treat gramnegative bacteria infection in mammals, such as humans; immunology; vaccines |
| 06/15/2010 | US7736856 determining whether catechin or an antibody has the same pharmacological effect as that of epigallocatechin gallate, on inhibiting cell proliferation, angiogenesis or cancer cell metastasis, as a neuroprotectant, a viricide, an antiallergen and as a antiarteriosclerotic agent |
| 06/15/2010 | US7736679 comprises curcumin and an essential oil of turmeric |
| 06/15/2010 | US7736678 Method of enhancing blood antioxidant activity ingesting a compound in the form of at least one form selected from amongst juice, powder, granule, tablet and capsule, which contains an effective amount of at least one vegetable selected from the group consisting of broccoli, spinach, parsley, komatsuna (Brassicad rapa L.) and japanese radish leaves, and at least one vegetable selected from amongst lettuce, cabbage and celery |
| 06/15/2010 | US7736675 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and/or a chitosan derivative and an antioxidant such as vitamin C and vitamin E |
| 06/15/2010 | US7736673 Stabilized pharmaceutical product |
| 06/15/2010 | US7736670 The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the |
| 06/15/2010 | US7736668 A delayed delivery drug dose to a fluid environment consists of a dose of drug, a second formulation with imbibes fluid and expands, a wall that confines both and permeable to the passage of fluid, a subcoat of hydroxyalkyl cellulose |
| 06/15/2010 | US7736667 Release rate constant over time for several hours within the early part of the release profile, confining the release to the upper GI tract; shell remains intact during entire period of drug release |
| 06/15/2010 | US7736666 Consists of naproxen, a butyl spacer and a nitrogen oxide (NO)-releasing nitrate group, linked together into a single molecule; useful as antiinflammatory agent and an analgesic |
| 06/15/2010 | US7736665 Implantable polymeric device for sustained release of buprenorphine |
| 06/15/2010 | US7736654 Proteins, polynucleotides, antibodies, transgenic animals, hybridoma; humoral or cellular immune response; pancreatic |
| 06/15/2010 | US7736636 Mixture of nicotine polymer and vasodilator; promote angiogenesis; therapy for erectile dysfunction, cardiovascular disorders, strokes |
| 06/15/2010 | US7736635 3-Maleimidyl-N-(2-{[3-maleimidyl-propionyl]-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-amino}-ethyl)-N-[(2-(methoxy-polyethoxy)-ethylcarbamoyl)-methyl]-propionamide linked to 2 polyoxyethyelne glycol residue and two antibodies or fragments; conjugate; biodegradable |
| 06/15/2010 | US7736634 Acryloyloxy-capped siloxane oligomer; copolymers with unsaturated monomers; antifouling coatings for underwater structures |
| 06/15/2010 | US7736628 Mixing a lactose fraction with small particle size with a carrier lactose contains amorphous lactose, exposing lactose mixture to a relative humidity of 85 % at a temp. from 20-40 degree C., then relative humidity of less than 20% at a temp.70 degree C. so that a modified lactose mixture is produced |
| 06/15/2010 | US7736627 The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of (1 7-((hydroxydi-2-thienylacetyl)oxy)-9, 9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane-bromide, with a simple monoclinic cell, and one or more adjuvants |
| 06/15/2010 | US7736626 HFA supension formulations containing an anticholinergic |
| 06/15/2010 | US7736624 derivatives of non-steroidal anti-inflammatory drugs that exhibit selective binding to cyclooxygenase-2 (COX-2) and that comprise functional groups allowing them to be used for medical diagnosis and/or as therapeutic agents; tissue-targeted therapy |
| 06/15/2010 | US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 06/15/2010 | CA2686480A1 New salts |
| 06/15/2010 | CA2599888C Preparation of taxanes from 9-dihydro-13-acetylbaccatin iii |
| 06/15/2010 | CA2564369C Delta crystalline form of ivabradine chlorhydrate, process for its preparation and pharmaceutical compositions containing it |
| 06/15/2010 | CA2555800C Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists |
| 06/15/2010 | CA2538915C [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 06/15/2010 | CA2529686C 2-acylaminothiazole derivative or salt thereof |
| 06/15/2010 | CA2521647C Novel hydroxamates as therapeutic agents |
| 06/15/2010 | CA2518224C Novel isothiazolopyrimidinones and isoxazolopyrimidinones and uses thereof |
| 06/15/2010 | CA2499691C Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury |
| 06/15/2010 | CA2495577C Novel benzoimidazole derivatives useful as antiproliferative agents |